Skip to main content
Clinical Trials/CTRI/2020/07/026854
CTRI/2020/07/026854
Not yet recruiting
Phase 1

A comparative study between the clinical effect of Ultrasound versus Fluoroscopy guided Sacroiliac Joint injection in Spondyloarthropathy.

R G Kar Medical College and Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
R G Kar Medical College and Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
R G Kar Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosed case of seronegative Spondyloarthropathy by ASAS criteria.
  • 2\. Pain primarily experienced between the upper level of the iliac crests and the gluteal fold.
  • 3\. Active sacroilitis clinically (positive finding of at least 3 of 6 following tests for SIJ pain)
  • i. Distraction or â??Gappingâ??
  • ii. FABER/Patrickâ??s Test
  • iii. Thigh Thrust or Posterior Pelvic Pain Provocational Test
  • iv. Gaenslenâ??s Test
  • v. Sacroiliac Joint Compression Test
  • vi. Sacral Thrust or Yeomanâ??s Test.
  • 4\. Poorly controlled by conservative treatment for 1 month by means of both pharmacological and non\-pharmacological therapy.

Exclusion Criteria

  • 1\. Severe peripheral arthritis with hip involvement.
  • 2\. Clinical findings and imaging studies suggest other obvious cause of the pain (e.g., central spinal stenosis with neurogenic claudication/myelopathy, foraminal stenosis or disc herniation with concordant radicular pain/radiculopathy, pyriformis syndrome, infection, tumour, fracture, pain related to spinal instrumentation).
  • 3\. Degenerative sacroiliac joint or complete ankylosis of sacroiliac joint (Grade IV).
  • 4\. Patient assume prone lying position to be difficult.
  • 5\. Allergy to lignocaine, contrast dye.
  • 6\. Presence of coagulation disorder or receiving anti\-coagulant therapy.
  • 7\. With other systemic disorders or active infection or other contraindications for corticosteroid injection.
  • 8\. Unwilling patient.
  • 9\. Patient unable to come to hospital for subsequent visits for follow\-up.
  • 10\. Has current skin disease over the injection site.

Outcomes

Primary Outcomes

Not specified

Similar Trials